Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACE Reno, Effect of Pico Cell Matrix on Patients With Micro-albuminuria, Proteinuria or CKD (of Any Degree) Due to Diabetes Mellitus, Autoimmune, Miscellaneous Aetiology

NCT07187713 is registered in ClinicalTrials.gov with Ace Cells Lab Limited as lead sponsor.

NCT NCT07187713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07187713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACE Reno, Effect of Pico Cell Matrix on Patients With Micro-albuminuria, Proteinuria or CKD (of Any Degree) Due to Diabetes Mellitus, Autoimmune, Miscellaneous Aetiology
Lead sponsor
Ace Cells Lab Limited
Phase
Phase 4
Overall status
Recruiting
Start date
September 20, 2025
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

auto immune disorders, chronc kidney disease stage 5, chronic kidney disease, chronic kidney disease (stage 3-4), chronic kidney disease (stages 4 and 5), diabetic nephropathies, hypertensive nephropathy, microalbuminuria